Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Jun;41(6):1377–1379. doi: 10.1128/aac.41.6.1377

Pharmacodynamic properties of BAY 12-8039 on gram-positive and gram-negative organisms as demonstrated by studies of time-kill kinetics and postantibiotic effect.

F J Boswell 1, J M Andrews 1, R Wise 1
PMCID: PMC163919  PMID: 9174203

Abstract

Time-kill kinetics of BAY 12-8039 were studied at two inocula against three strains each of Bacteroides fragilis, Escherichia coli, Staphylococcus aureus, Haemophilus influenzae, and Streptococcus pyogenes. The postantibiotic effects of BAY 12-8039 were studied on three strains each of E. coli, S. aureus, H. influenzae, Streptococcus pyogenes, and Streptococcus pneumoniae. The pharmacodynamic data demonstrated that BAY 12-8039 has marked activity against gram-positive and gram-negative organisms (under both anaerobic and aerobic conditions) and anaerobes. BAY 12-8039 also exhibited a postantibiotic effect of >1 h for all strains except one E. coli strain.

Full Text

The Full Text of this article is available as a PDF (118.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cooper M. A., Andrews J. M., Wise R. Bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions. J Antimicrob Chemother. 1991 Sep;28(3):399–405. doi: 10.1093/jac/28.3.399. [DOI] [PubMed] [Google Scholar]
  2. Griggs D. J., Piddock L. J., Wise R. The killing action of fleroxacin upon Bacteroides fragilis. J Antimicrob Chemother. 1989 Jan;23(1):53–58. doi: 10.1093/jac/23.1.53. [DOI] [PubMed] [Google Scholar]
  3. Hyatt J. M., Nix D. E., Stratton C. W., Schentag J. J. In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1995 Aug;39(8):1711–1716. doi: 10.1128/aac.39.8.1711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Lewin C. S., Morrissey I., Smith J. T. The bactericidal activity of sparfloxacin. J Antimicrob Chemother. 1992 Nov;30(5):625–632. doi: 10.1093/jac/30.5.625. [DOI] [PubMed] [Google Scholar]
  5. Zabinski R. A., Walker K. J., Larsson A. J., Moody J. A., Kaatz G. W., Rotschafer J. C. Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolones. Antimicrob Agents Chemother. 1995 Feb;39(2):507–512. doi: 10.1128/aac.39.2.507. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES